HIV integrase inhibitors from pyridoxine
US8742123B2 · kind B2 · utility
4Cited by
0References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 2009 |
| Grant date | Jun 3, 2014 |
| Priority date | — |
| Expiry date | Jan 14, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to pyridoxine (vitamin B6) derived compounds of formula (I), pharmaceutically acceptable salts, or solvates thereof, wherein R1, R2, R4, A, L B1 and B2 are as defined in the specification, and pharmaceutical compositions comprising the compounds. Compounds of formula (I) inhibit Human Immunodeficiency Virus (HIV)-integrase enzyme and are useful for preventing and treating HIV infection and AIDS.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.